The Delhi high court has paved the way for domestic drugmaker Natco Pharma Ltd to launch a generic version of Roche’s Risdiplam, a drug used to treat spinal muscular atrophy (SMA)—a rare genetic disorder that causes motor neuron degeneration and progressive muscle weakness.
In today’s rapidly evolving business environment, legal strategy is no longer confined
New Delhi: Days after the Supreme Court questioned the functioning of the
The rollout of the Digital Personal Data Protection Act, 2023 (DPDP Act)
By simplifying legalities around digital trade across borders, India can leverage its
New Delhi: The Supreme Court on Monday observed that the price surge
This website is for informational purposes only and is not intended to advertise or solicit work as per the Bar Council of India rules. By accessing www.foresightlawoffices.com, you acknowledge that you are seeking information about Foresight Law voluntarily. Nothing on this site constitutes legal advice or creates a lawyer-client relationship. Foresight Law is not responsible for any actions taken based on the content here. External links do not imply endorsement. Please do not share confidential information via this website. For details, review our Privacy Policy and Terms of Use.